Please assess the completion status of the following clinical trial:

Trial Title: Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Be willing and able to sign consent forms;~* Be eligible for menstrual regulation (MR) services according to clinician's assessment;~* Be willing to undergo a surgical evacuation if necessary;~* Be willing to provide a urine sample prior to administration of the mifepristone~* Have ready and easy access to a telephone and~* Agree to comply with the study procedures and visit schedule~Exclusion Criteria:~* • Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass;~  * Chronic renal failure;~ * Concurrent long-term corticosteroid therapy;~ * History of allergy to mifepristone, misoprostol or other prostaglandin;~ * Hemorrhagic disorders or concurrent anticoagulant therapy;~ * Inherited porphyrias; or~ * Other serious physical or mental health conditions.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mifepristone-misoprostol (Type: EXPERIMENTAL): Women will receive 200mg oral mifepristone followed in 24-48h by 800mcg buccal misoprostol

Based on this trial design, predict the completion outcome and termination type (if applicable).